Definition and Purpose of Form 8820
Form 8820, Orphan Drug Credit, is a tax form issued by the Internal Revenue Service (IRS) designed for corporations to claim the orphan drug credit. This credit is available for certain expenses related to the development of orphan drugs. Orphan drugs are pharmaceutical agents developed to treat rare medical conditions, often called orphan diseases. The IRS allows taxpayers to file this form to benefit from tax incentives to encourage research and development in this niche field, which is vital given the high costs and relatively low return due to smaller patient populations.
- Orphan Drug Definition: Refers to medications or treatments intended for rare diseases.
- Tax Incentive Aim: Create financial incentives for developing treatments for conditions affecting a small percentage of the population.
How to Use the Form 8820 (Rev September 2018)
To correctly utilize Form 8820, it's essential to understand both the eligibility criteria and the step-by-step process of completing the form accurately.
-
Determine Eligibility:
- Verify that the expenses related to your drug development qualify under the orphan drug criteria.
- Confirm that the drug or treatment is designated as an orphan product under federal regulations.
-
Accurate Record-keeping:
- Maintain detailed records of all qualifying expenses, such as clinical testing and research costs.
- Ensure records are thorough and align with the IRS requirements to support your claim in the event of an audit.
-
Form Completion:
- Fill out the form accurately, ensuring all relevant fields, including cost details and eligibility confirmations, are properly entered.
- Attach any necessary documentation that supports the claims on the form.
Steps to Complete the Form 8820 (Rev September 2018)
Completing Form 8820 involves several specific steps:
-
Header Information: Start with basic identification details such as name, address, and Taxpayer Identification Number (TIN).
-
Calculate the Credit:
- Carefully calculate the qualified clinical testing expenses.
- Assess the amount of credit you are eligible to claim, typically a percentage of these expenses, following the IRS guidelines.
-
Compliance Review:
- Double-check all figures and entries for accuracy.
- Ensure compliance with all IRS rules related to form submissions.
-
Documentation:
- Attach supporting documentation to substantiate your claim. This may include expenditure receipts, reports, and designations as an orphan drug.
IRS Guidelines for Form 8820
The IRS provides specific guidelines for corporations on how to file Form 8820 effectively:
- Official Instructions: Refer to the official IRS instructions document for precise directions on qualifying expenses.
- Filing Assistance: Consulting with tax professionals or using IRS-preapproved software can aid in correctly filling out the form and avoiding errors.
- Regular Updates: Pay attention to IRS updates on form revisions and changes in tax law concerning the orphan drug credit.
Filing Deadlines and Important Dates
To maximize the benefits of the orphan drug credit, meeting specific filing deadlines is crucial:
- Standard Deadline: Form 8820 is typically attached to your annual tax return and follows the same deadline.
- Extensions and Exceptions: Be aware of potential extensions for filing, but understand that these may come with certain conditions or limitations.
Who Typically Uses Form 8820
Form 8820 is predominantly utilized by businesses and organizations engaged in the development of pharmaceutical treatments for rare diseases:
- Pharmaceutical Corporations: Entities heavily invested in drug research and development.
- Non-Profit Organizations: Engaged in advancing treatments for rare diseases.
- Research Institutions: Partnering with pharmaceutical companies or conducting independent research.
Key Elements and Sections of Form 8820
Understanding the key sections of Form 8820 can aid in accurate and efficient completion:
- Part I - Computation of Credit: Involves calculations related to qualified clinical testing expenses.
- Part II - Additional Information: Requests further details supporting the orphan drug credit claim, such as product descriptions and certifications.
- Final Review: Double-check all entries for accuracy and ensure alignment with supporting documents.
Software Compatibility with Form 8820
Many tax software solutions can facilitate the filing of Form 8820, simplifying the process and reducing errors:
- Compatible Software Options: Products like TurboTax and QuickBooks are often updated to assist with tax credit forms.
- Integration Features: Look for software capable of importing data from your accounting systems to streamline form completion.
Eligibility Criteria and Requirements for Form 8820
Eligibility for the orphan drug credit via Form 8820 depends on specific criteria outlined by the IRS:
- Qualified Expenses: Include only expenses directly related to developing orphan drugs.
- Designation Requirements: The drug must be officially recognized as an orphan product.
Employing these steps and understanding the detailed requirements for each section of Form 8820 can ensure that businesses accurately claim and maximize the orphan drug credit benefits while remaining compliant with IRS regulations.
